Tech Company Financing Transactions

Immunomic Therapeutics Funding Round

Immunomic Therapeutics, operating out of Hershey, scored $1.5 million in investment from Life Sciences Greenhouse of Central Pennsylvania and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

15010 Broschart Rd. 250
Hershey, MD 20850
USA

Phone

(301) 968-3501

Website

www.immunomix.com

Email Address

[email protected]

Overview

Immunomic Therapeutics, Inc. is developing next generation vaccines focusing on allergy immunotherapy. The Company's first vaccine will be for Japanese Red Cedar, JRC-LAMP-vax.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

William Hearl

        

Chief Financial Officer

Eric Winzer

        

Chief Scientific Officer

Teri Heiland

        

Vice President

Andrew Eisen

        

VP - Bus. Development

Sia Anagnostou

        

VP - Operations

Timothy Coleman

        

VP - Regulatory Affairs

Louise Peltier

        

Browse more venture capital transactions:

Prev: 6/30/2012: Sundrop Fuels venture capital transaction
Next: 6/30/2012: GG Digital venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary